ID   INMi001-A-1
AC   CVCL_YR32
SY   USH2A-RP-iPSC clone MS3F7
DR   Wikidata; Q94317986
RX   PubMed=31909088;
CC   From: Institute for Neurosciences of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 12601; USH2A; Simple_corrected; p.Cys759Phe (c.2276G>T); ClinVar=VCV000002356; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31909088).
CC   Sequence variation: Mutation; HGNC; 12601; USH2A; Simple; p.Glu767Serfs*21 (c.2299delG); ClinVar=VCV000002351; Zygosity=Heterozygous (PubMed=31909088).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UJ75 ! INMi001-A
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 7
//
RX   PubMed=31909088; DOI=10.1016/j.omtm.2019.11.016;
RA   Sanjurjo-Soriano C., Erkilic N., Baux D., Mamaeva D., Hamel C.P.,
RA   Meunier I., Roux A.-F., Kalatzis V.;
RT   "Genome editing in patient iPSCs corrects the most prevalent USH2A
RT   mutations and reveals intriguing mutant mRNA expression profiles.";
RL   Mol. Ther. Methods Clin. Dev. 17:156-173(2020).
//